These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21292164)

  • 1. Nascent peptide in the ribosome exit tunnel affects functional properties of the A-site of the peptidyl transferase center.
    Ramu H; Vázquez-Laslop N; Klepacki D; Dai Q; Piccirilli J; Micura R; Mankin AS
    Mol Cell; 2011 Feb; 41(3):321-30. PubMed ID: 21292164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of drug-dependent ribosome stalling.
    Vazquez-Laslop N; Thum C; Mankin AS
    Mol Cell; 2008 Apr; 30(2):190-202. PubMed ID: 18439898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed drug-dependent ribosome stalling.
    Ramu H; Mankin A; Vazquez-Laslop N
    Mol Microbiol; 2009 Feb; 71(4):811-24. PubMed ID: 19170872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.
    Lovmar M; Vimberg V; Lukk E; Nilsson K; Tenson T; Ehrenberg M
    Biochimie; 2009 Aug; 91(8):989-95. PubMed ID: 19463886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statics of the ribosomal exit tunnel: implications for cotranslational peptide folding, elongation regulation, and antibiotics binding.
    Fulle S; Gohlke H
    J Mol Biol; 2009 Mar; 387(2):502-17. PubMed ID: 19356596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the use of the antibiotic chloramphenicol to target polypeptide chain mimics to the ribosomal exit tunnel.
    Mamos P; Krokidis MG; Papadas A; Karahalios P; Starosta AL; Wilson DN; Kalpaxis DL; Dinos GP
    Biochimie; 2013 Sep; 95(9):1765-72. PubMed ID: 23770443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nascent polypeptide sequences that influence ribosome function.
    Cruz-Vera LR; Sachs MS; Squires CL; Yanofsky C
    Curr Opin Microbiol; 2011 Apr; 14(2):160-6. PubMed ID: 21342782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for translational stalling by human cytomegalovirus and fungal arginine attenuator peptide.
    Bhushan S; Meyer H; Starosta AL; Becker T; Mielke T; Berninghausen O; Sattler M; Wilson DN; Beckmann R
    Mol Cell; 2010 Oct; 40(1):138-46. PubMed ID: 20932481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for the role of isomerization in nascent peptide movement through the ribosomal tunnel.
    Agmon IC
    FASEB J; 2012 Jun; 26(6):2277-82. PubMed ID: 22389440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetry at the active site of the ribosome: structural and functional implications.
    Agmon I; Bashan A; Zarivach R; Yonath A
    Biol Chem; 2005 Sep; 386(9):833-44. PubMed ID: 16164408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes produced by bound tryptophan in the ribosome peptidyl transferase center in response to TnaC, a nascent leader peptide.
    Cruz-Vera LR; Gong M; Yanofsky C
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3598-603. PubMed ID: 16505360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisite ribosomal stalling: a unique mode of regulatory nascent chain action revealed for MifM.
    Chiba S; Ito K
    Mol Cell; 2012 Sep; 47(6):863-72. PubMed ID: 22864117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal sequence-independent membrane targeting of ribosomes containing short nascent peptides within the exit tunnel.
    Bornemann T; Jöckel J; Rodnina MV; Wintermeyer W
    Nat Struct Mol Biol; 2008 May; 15(5):494-9. PubMed ID: 18391966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RMF inactivates ribosomes by covering the peptidyl transferase centre and entrance of peptide exit tunnel.
    Yoshida H; Yamamoto H; Uchiumi T; Wada A
    Genes Cells; 2004 Apr; 9(4):271-8. PubMed ID: 15066119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal crystallography: peptide bond formation and its inhibition.
    Bashan A; Zarivach R; Schluenzen F; Agmon I; Harms J; Auerbach T; Baram D; Berisio R; Bartels H; Hansen HA; Fucini P; Wilson D; Peretz M; Kessler M; Yonath A
    Biopolymers; 2003 Sep; 70(1):19-41. PubMed ID: 12925991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
    Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
    Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrest peptides: cis-acting modulators of translation.
    Ito K; Chiba S
    Annu Rev Biochem; 2013; 82():171-202. PubMed ID: 23746254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide.
    Vázquez-Laslop N; Ramu H; Klepacki D; Kannan K; Mankin AS
    EMBO J; 2010 Sep; 29(18):3108-17. PubMed ID: 20676057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of intraribosomal part of nascent polypeptide.
    Kolb VA
    Biochemistry (Mosc); 2010 Dec; 75(13):1517-27. PubMed ID: 21417992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosomal tolerance and peptide bond formation.
    Yonath A
    Biol Chem; 2003; 384(10-11):1411-9. PubMed ID: 14669983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.